Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

50.350
+0.2500.50%
Volume:21.91M
Turnover:1.12B
Market Cap:209.25B
PE:37.02
High:51.900
Open:50.350
Low:50.200
Close:50.100
52wk High:54.450
52wk Low:28.480
Shares:4.16B
HK Float Shares:4.16B
Volume Ratio:1.62
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.360
ROE:11.38%
ROA:7.60%
PB:3.71
PE(LYR):37.02
PS:7.56

Loading ...

Wuxi Biologics (Cayman) Stock Climbs 3.8% in Hong Kong

Dow Jones
·
Jun 12

Movement Alert|WuXi Biologics Rises 3.21% in Regular Trading, Aggressive Buyback Program and Sector Rebound Drive Recovery

Market Focus
·
Jun 12

WuXi Biologics makes S&P Global Sustainability Yearbook China edition for fourth straight year

Reuters
·
Jun 11

WUXI BIO issues 1.48 million new shares on option exercise and buys back 3.39 million shares under new mandate

Bulletin Express
·
Jun 11

WUXI BIO Executes Share Buyback, Spending Nearly HK$100 Million on June 11th

Stock News
·
Jun 11

Movement Alert|WuXi Biologics Falls 4.21% in Regular Trading, Continued Pressure from US Regulatory Actions Against WuXi Group

Market Focus
·
Jun 10

WUXI BIO completes HK$74.88 million share buyback, lifting pending cancellations to 21.10 million shares

Bulletin Express
·
Jun 09

WUXI BIO Executes Share Buyback, Spending HK$74.9 Million on June 9

Stock News
·
Jun 09

WuXi Biologics files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 09

WUXI BIO Grants 288,400 Restricted Shares

Stock News
·
Jun 09

Wuxi Biologics (Cayman) Stock Sheds 1.4% in Hong Kong

Dow Jones
·
Jun 09

Movement Alert|WuXi Biologics Falls 3.09% in Regular Trading, CXO Sector Extends Multi-Day Selloff Amid US Biosecurity Legislation Concerns

Market Focus
·
Jun 09

Key Corporate Developments and Share Repurchases Highlight Hong Kong Market Activity

Stock News
·
Jun 09

WUXI BIO Executes HK$200 Million Share Repurchase on June 8

Stock News
·
Jun 08

Wuxi Biologics (Cayman) Stock Slides 7.2% in Hong Kong

Dow Jones
·
Jun 08

Assessing WuXi Biologics (SEHK:2269) Valuation After Its Recent Share Price Momentum Shift

Simply Wall St.
·
Jun 07

Is WuXi Biologics (SEHK:2269) Offering Value After Its Recent Share Price Recovery?

Simply Wall St.
·
Jun 06

WUXI BIO Executes Major Share Buyback, Spending Nearly HK$100 Million

Stock News
·
Jun 05

WuXi Biologics tops out Singapore modular drug product facility, targets 100 million units annual output

Reuters
·
Jun 05

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05